CervoMed Inc. CRVO
- neflamapimod — Dementia with Lewy Bodies Phase 2
- neflamapimod — Non-Fluent Variant Primary Progressive Aphasia Phase 2
Home › Targets › p38α MAP kinase
p38α MAP kinase (1 companies · 2 programs)
Companies with an active program directed at p38α MAP kinase.